Editor’s Note: Today’s post comes from Michael Couchman, a PhD candidate in history at Queen’s University in Kingston, Ontario. It’s based off his presentation at the Cannabis: Global Histories conference held at the University of Strathclyde, Glasgow, from April 19-20, 2018. Enjoy!
At the United Nations General Assembly Special Session on the World Drug Problem in 2016, Canadian Health Minister Jane Philpott proclaimed that, “Our approach to drugs must be comprehensive, collaborative and compassionate. It must respect human rights while promoting shared responsibility. And it must have a firm scientific foundation. In Canada, we will apply these principles with regard to marijuana.” Although Canada’s upcoming decision to legalize cannabis presents considerable difficulties in the context of the many international drug control treaties to which it adheres, this challenge presents a unique opportunity to promote some much-needed reforms in the realm of multilateral drug laws. Being the first G7 country to tax and regulate cannabis at the national level, Canada has the potential to help redefine the global regulatory apparatus and its directives concerning cannabis and other illicit drugs.
Michael Couchman presents his work at the Cannabis: Global Histories conference at the University of Strathclyde, Glasgow, on April 20, 2018. Photo by Morgan Scott, Breathe Images
Editor’s Note: Did you hear? Yesterday, Canada’s Senate passed legislation legalizing recreational marijuana use for adults. Legalization will officially take place in October 17, 2018, in an effort to “take market share away from organized crime and protect the country’s youth,” Prime Minister Justin Trudeau said. Do you think Canada passed the law because they read Matthew DeCloedt’s post, published on Tuesday, about human rights arguments that advanced the passage of Canadian medical marijuana laws years before? Probably! Here’s more from DeCloedt in a video taken at the Cannabis: Global Histories conference, so you can hear the man himself explain his research and work. Enjoy!
Matthew DeCloedt – Global Histories: Cannabis from Points ADHS on Vimeo.
Editor’s Note: This post is brought to you by Cynthia Belaskie and Lucas Richert. Richert is a lecturer in history at University of Saskatchewan and Belaskie is a senior advisor at McMaster University. Enjoy!
We weren’t left to wait in the B.C. rain. After presenting our IDs at the security station outside Tilray’s medical cannabis facility in Nanaimo, and once we were confirmed as being on the official “list,” it took less than a minute to enter the recently constructed $30 million, 65,000 square-foot facility.
There were four of us taking the tour of Tilray, one of Canada’s licensed producers of medical marijuana. We were part of a SSHRC-funded conference in the history of drugs and alcohol at Vancouver Island University, and this was one of the activities available to us as participants in the event.
Philippe Lucas VP of Tilray a medical marijuana business is seen here in the grow room in Nanaimo August 14, 2014. (John Lehmann/The Globe and Mail)
Our guide was Phillipe Lucas, Vice-President of Patient Services at Tilray. He walked us through the electric gate and led us into a cozy holding room filled with bottles of San Pellegrino, a weigh scale, and a flat screen TV flashing images of the building’s construction. A former city councilor in Victoria, an expert witness on marijuana in Canada, and one-time dispensary owner, Philippe was handsome. He spoke quickly, laughed easily, and possessed an air of mischief, too.
Over the past ten years, Phillipe has published peer-reviewed articles on cannabis’s therapeutic effects on patients in top academic journals around the world. In particular, as a PhD student at the University of British Columbia, he has been working on a concept called the cannabis substitution theory, which seeks to understand the behaviours and choices of marijuana-using patients in the medical marketplace. Besides this, he helped co-found a Canadian chapter of the Multidisciplinary Association for Psychedelic Studies.
We deposited our belongings on the leather chairs in the cozy waiting room, leaving our phones and cameras behind, and Phillipe explained the building was a Level 9 security complex. Level 10 was reserved for nuclear products and the facility has been described by Charlie Smith as “a vault wrapped by Fort Knox wrapped in a castle.” No pictures allowed. No videos, either.
With security passes on display around our necks, we set off. We engaged in an intricate dance as we tapped in and out of each fortified and sanitized room. Our graceless choreography, made ever more awkward as we stood outside each room and robed and disrobed to prevent contaminating the delicate crops, was all caught on internal security cameras – lots and lots of cameras, in fact. It is understandable, isn’t it? Just imagine what would happen if this stuff made its way on to the streets.